Transcript Slide 1
Each year there are over 700,000 deaths worldwide due to fake TB and Malaria medications alone. We address this issue by working with brand owners to engage the consumer in the fight against counterfeits ISSM – October 3, 2011 Alison Martin About Sproxil • Incorporated 2009, privately held – Experiencing rapid growth – Expanding global presence in high growth markets – No pharma shareholders • • • • HQ in Cambridge, MA (Greater Boston Area) Subsidiaries in Nigeria, Ghana, Kenya & India Multiple patents filed and granted Local presence with multi lingual, diverse staff. 2 Specific Market Challenges • Distribution chain participants may not be trustworthy • Unreliable basic infrastructure • Severely limited financial and human resources • Law enforcement does not have sufficient reach or resources • Counterfeiters are constantly innovating 3 Sproxil’s Mobile Product Authentication™ Actions at point of purchase 2 Send by Text or Web 1 Reveal Code Pseudo random, one-time use codes 3 Instant response OR Trust is assured No need to trust supply chain members No special equipment or training needed Free for consumer Sproxil has World-class Clients A sample of our clients: • GlaxoSmithKline uses Sproxil MPA™ technology to protect Ampiclox™ • Johnson & Johnson’s JanssenCilag (Nizoral®) • Merck Serono’s Glucophage® – Sproxil works with manufacturers and distributors alike 5 The Mobile Authentication Service (MAS) in Nigeria Consumer: Scratch and Text Codes to the Cloud Multiple Options for Various Supply Chain Levels 1. Covert PIN code 2. Overt 2D barcode • Could contain covert taggants in ink 3. Overt serial number • Could be encoded, pseudo-random 7 SMS + Voice Call center number for additional assistance Rapid text message response with “OK” or “FAKE” Trust is assured between consumer and pharmacist No special equipment or training needed. Works with basic phones Sproxil Combines Secure Interlocking Technologies Making counterfeiting unprofitable™ Self-destructing codes Free-to-patient SMS Tamper evidence SMS Shortcode No device investment Mass serialization Competing Anti-Counterfeit Technologies Chemicals RFID Barcodes Holograms BASF, DuPont McKesson YottaMark, Covectra Hologram Industries, Novavision $$$$ $$$ $, but… $, but… Expensive No consumer capability No support infrastructure for consumers Requires consumer equipment Compromised Easy to copy Consumer Consumer capable capable Lower cost cost CONFIDENTIAL AND PROPRIETARY © 2010, Sproxil,Lower Inc. No special equipment needed Solution is robust and well-tested Slide: 10 Cascading Authentication: For Regions with High Counterfeiting Incidents Wholesaler Uses 2D barcode Distributor Uses 2D barcode OR Multi-use overt code Pharmacist Multi-use overt code Patient Uses single-use covert scratch or peel-off code 11 Cascading Authentication: Entire Supply Chain Can Be Secured Distributor Genuine Mobile: 2D Barcode Mobile or Web: Overt Code Voice: Call Center Available Wholesaler Pharmacist Consumer Genuine Genuine Genuine 2D Barcode Overt Code Call Center Overt Code Call Center Covert Code Call Center Cascading Authentication: Entire Supply Chain Can Be Secured Over Multiple Continents ! Diversion 13 Sproxil’s Innovative Business Model: Everyone Benefits win win win Consumers Government Pharma Except…. lose Counterfeiters 14 Sproxil’s Innovative Business Model: Everyone Benefits win win win Consumers Government Pharma Cost is low or even free Avoid negative health outcomes Save money 15 Sproxil’s Innovative Business Model: Everyone Benefits win Consumers win Government win Pharma Safeguard the health of the nation Reduce health insurance costs & reimbursement fraud No cost to government 16 Sproxil’s Innovative Business Model: Everyone Benefits win win win Consumers Government Pharma Protect patients & boost compliance Gain market intelligence Avoid brand damage Increase sales, regain market share 17 /Customer Support Desk Insights Learnings Impact Location of potentially counterfeit or substandard medicines Enables brand owners to act quickly to protect their consumers What medical questions are patients asking? Enables brand owners to retrain or reinforce the benefits of certain medications Where are customers purchasing products? Understand market penetration and adjust marketing campaigns 18 Counterfeiters “Counterpunch” • Sproxil has detected adversary reactions to deployed solution 2010: Dilution – selling genuine and fake blisters in one box. Consumer reports issue & incident resolved 2011: Deceiving Consumers – attempts at convincing consumers brand owner no longer using Sproxil solution. Consumer reports issue & incident resolved 201X: Fake labels? Fake Shortcode? We are prepared and will keep resolving issues working closely with regulatory agencies, genuine manufacturers and consumers Strength in Partnerships: Demonstrated Collaboration for Success Government Regulators NGOs Relief Workers Professional Associations (Doctors, Nurses) Industry Trade Groups & Pharma Co. Patient Groups 20 Sproxil’s Progress to Date • >200,000 unique mobile numbers (“patients”) served • Thousands of SMS received per day • 9 SKUs in Market; many more in pipeline • Operations in Nigeria, Ghana, Kenya, Tanzania, and India. Recognition of Sproxil’s Impact President Clinton congratulates Sproxil CEO Dr. Gogo Photo by CGI “This is a genuinely remarkable achievement... (it's) empowering... putting people in charge of their own healthcare.” President Bill Clinton Sproxil, Inc 1035 Cambridge Street Cambridge, MA 02141 USA [email protected] Protecting Brands Globally ™ +1 209 877 7694 America | Asia | Africa Sproxil.com